Sandbox:UT: Difference between revisions
Usama Talib (talk | contribs) No edit summary |
Usama Talib (talk | contribs) No edit summary |
||
Line 69: | Line 69: | ||
| colspan="2" |14 | | colspan="2" |14 | ||
| colspan="2" |14 | | colspan="2" |14 | ||
| | |84 days | ||
|- | |- | ||
|Expected Days for each Chapter | |'''Expected Days for each Chapter''' | ||
| colspan="2" |49 | | colspan="2" |49 | ||
| colspan="2" |89 | | colspan="2" |89 | ||
Line 80: | Line 80: | ||
|364 days | |364 days | ||
|- | |- | ||
|Time line | |'''Expected Time line''' | ||
| colspan="2" |October 1st week | | colspan="2" |October 2017, 1st week | ||
| colspan="2" |January 1st week | | colspan="2" |January 2018,1st week | ||
| colspan="2" |February 4th week | | colspan="2" |February 2018, 4th week | ||
| colspan="2" |April 3rd week | | colspan="2" |April 2018, 3rd week | ||
| colspan="2" |July 1st week | | colspan="2" |July 2018, 1st week | ||
| colspan="3" |August 4th week | | colspan="3" |'''August 2018, 4th week''' | ||
|} | |} | ||
Line 134: | Line 134: | ||
|'''229''' | |'''229''' | ||
|- | |- | ||
|Projected Microchapters | |'''Projected Microchapters''' | ||
| colspan="2" |45 | | colspan="2" |45 | ||
| colspan="2" |89 | | colspan="2" |89 | ||
Line 148: | Line 148: | ||
* Number of fellows = 15 | * Number of fellows = 15 | ||
* 15 chapters are completed in 10 days | * 15 chapters are completed in 10 days | ||
| | | colspan="2" |30 days | ||
| | | colspan="2" |60 days | ||
| | | colspan="2" |40 days | ||
| | | colspan="2" |14 days | ||
| | | colspan="2" |21 days | ||
| | | colspan="2" |16 days | ||
| | | colspan="2" |15 days | ||
| | |196 days | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |'''Review Processing Time (days)''' | ||
| | | colspan="2" |14 | ||
| | | colspan="2" |14 | ||
| | | colspan="2" |14 | ||
| | | colspan="2" |14 | ||
| | | colspan="2" |14 | ||
| | | colspan="2" |14 | ||
| | | colspan="2" |14 | ||
| | |98 days | ||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| | |'''Expected Days for each Chapter''' | ||
| | | colspan="2" |44 | ||
| | | colspan="2" |74 | ||
| | | colspan="2" |54 | ||
| | | colspan="2" |28 | ||
| | | colspan="2" |35 | ||
| | | colspan="2" |30 | ||
| | | colspan="2" |29 | ||
| | |294 days | ||
| | |- | ||
| | |'''Expected Time Line''' | ||
| | | colspan="2" |October 2018, 3rd week | ||
| | | colspan="2" |January 2019, 1st week | ||
| | | colspan="2" |March 2019, 1st week | ||
| | | colspan="2" |April 2019, 1st week | ||
| | | colspan="2" |May 2019, 2nd week | ||
| colspan="2" |June 2019, 2nd week | |||
| colspan="3" |'''July 2019, 2nd week''' | |||
|} | |} | ||
Revision as of 20:45, 17 August 2017
Wikidoc Internal Medicine Texbook | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Subject | Endochrinology | Gastrointestinal | Rheumatology | Pulmonary | Nephrology | Hematology | Total | ||||||
Microchapters | Total | Left | Total | Left | Total | Left | Total | Left | Total | Left | Total | Left | |
71 | 39 | 96 | 89 | 54 | 47 | 58 | 46 | 59 | 64 | 51 | 47 | 332 | |
Projected Microchapters | 50 | 111 | 59 | 59 | 80 | 59 | 418 | ||||||
Days projected
|
35 days | 75 days | 40 days | 40 days | 55 days | 40 days | 280 days | ||||||
Review Processing Time (days) | 14 | 14 | 14 | 14 | 14 | 14 | 84 days | ||||||
Expected Days for each Chapter | 49 | 89 | 54 | 54 | 69 | 54 | 364 days | ||||||
Expected Time line | October 2017, 1st week | January 2018,1st week | February 2018, 4th week | April 2018, 3rd week | July 2018, 1st week | August 2018, 4th week |
Wikidoc Other Textbooks | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Subject | Psychiatry | Neurology | Peds/Developmental | Dermatology | ObGyn | Ophthalmology | Nutrition | Total | |||||||
Microchapters | Total | Left | Total | Left | Total | Left | Total | Left | Total | Left | Total | Left | Total | Left | |
36 | 36 | 77 | 71 | 49 | 49 | 18 | 14 | 33 | 27 | 18 | 17 | 17 | 15 | 229 | |
Projected Microchapters | 45 | 89 | 60 | 17 | 35 | 21 | 19 | 286 | |||||||
Days projected
|
30 days | 60 days | 40 days | 14 days | 21 days | 16 days | 15 days | 196 days | |||||||
Review Processing Time (days) | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 98 days | |||||||
Expected Days for each Chapter | 44 | 74 | 54 | 28 | 35 | 30 | 29 | 294 days | |||||||
Expected Time Line | October 2018, 3rd week | January 2019, 1st week | March 2019, 1st week | April 2019, 1st week | May 2019, 2nd week | June 2019, 2nd week | July 2019, 2nd week |
Viral Hepatitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hepatitis A | Hepatitis B | Hepatitis C | Hepatitis D | Hepatitis E | Hepatitis F | Hepatitis G | Other | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
• EBV hepatitis • CMV hepatitis • HSV hepatitis • Coxsackie B virus hepatitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Non-infectious Hepatitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Alcoholic hepatitis | Non-alcoholic steatohepatitis (NASH) | a-1 antitrypsin defieciency | Autoimmune hepatitis | Obstructive hepatitis | Drug related hepatitis | Toxin related hepatitis | Ischemic hepatitis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
•Gall stone •Tumor | •Isoniazid •NSAIDs •Beta-lactam antibiotics •Sulfa-containing drugs •HAART | Chemicals | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Obsessive compulsive disorder RSG
Obsessive compulsive disorder | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Screen for OCD; if present, assess severity and associated conditions* | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mild to moderate OCD, Patient has good insight | Severe OCD OR Pateint has poor insight OR Moderate to severe co-occuring hoarding, tics, depresion or anxiety disorder | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Improvement within 12 weeks? | Improvement within 12 weeks | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Negative Culture ❑ Complete 5 day Antibiotic Course | Confirmed SBP ❑ Narrow the spectrum based on the susceptibility to complete the 5 day course | Culture Negative ❑ No Antibiotics indicated | Culture Positive ❑ Bacterascites: Repeat diagnostic paracentesis when the culture growth is discovered | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Code to Fix Refereneces
Classification
UTI | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Uppper | Lower | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pyelonephritis | Cystitis | Prostatitis | Uretheritis | Asymptomatic Bacteriuria | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pyelonephritis | Etiology | Pathogen | Duration and Treatment | Acute Bacterial*Chronic bacterial*Inflammatory chronic*Non-inflammatory chronic*Asymptomatic | Non-infectious | Infectious | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Traumatic cystitis*Interstitial Cystitis*Eosinophilic cystitis*Hemorrhagic cystitis*Foreign body cystitis*Cystitis cystica*Emphysematous cystitis*Cystitis glandularis | *Bacteria*Fungi*Viruses*Parasites | *Acute uncomplicated cystitis*Complicated cystitis*Recurrent/Chronic Cystitis | *urinary crystals*Chemicals*Stevens-Johnson syndrome*Spermicides | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal Reference
Raas-Rothschild A, Spiegel R (2010 Jan 28). "Mucolipidosis III Gamma". GeneReviews®. PMID 20301784. Check date values in: |access-date=, |date=
(help); |access-date=
requires |url=
(help)
Book Reference
Pathology image reference/website
Radiopedia Image reference
Color codes for table
BLUE: |align="center" style="background:#4479BA; color: #FFFFFF;" |
GRAY: |style="background: #F5F5F5; padding: 5px text-align:center" | +
KHAKI:|style="background: #F0E68C; padding: 5px text-align:center" | +
PALE TORQOUI...:|style="background: #AFEEEE; padding: 5px text-align:center" | -
Brown:|style="background: #A52A2A; padding: 5px text-align:center" | +
Image copying
Image copying with text

Table for D/D of cystitis
Diseases | Diagnostic tests | Physical Examination | Symptoms | Past medical history | Other Findings | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Urinalysis | Urine Culture | Gold Standard | Fever | Suprapubic Tenderness | Discharge | Inguinal Lymphadenopathy | Hematuria | Pyuria | Frequency | Urgency | Dysuria | |||
Cystitis | *Nitrite +ve
*Leukocyte estrase+ve *WBCs *RBCs |
>100,000CFU/mL | Urinary culture | ✔ | ✔ | - | ✔ | ✔ | ✔ | ✔ | ✔ | ✔ |
| |
Urethritis | *Positive leukocyte esterase test or >10 WBCs
*Mucous threads in the morning urine |
- | *Gram stain
*Mucoid or purulent discharge |
✔ | - | Urethral discharge | ✔ | - | ✔ | - | - | ✔ |
|
Tachycardia, diaphoresis, hypertension, tremors, mydriasis, positional nystagmus, tachypnea |
Bacterial Vulvovagintis | - | - | Gram Stain | ✔ | - | Vaginal discharge | ✔ |
|
| |||||
Cervicitis | - | - | culture for gonococcal cervicitis | ✔ | - |
endocervical exudate |
- | ✔ | - | - | ✔ |
|
1-a purulent or mucopurulent endocervical exudate
2-Sustained endocervical bleeding easily induced by a cotton swab 3->10 WBC in vaginal fluid, in the absence of trichomoniasis, may indicate endocervical inflammation caused specifically by C. trachomatis or N. gonorrhea | |
Prostatitis | 10-20 leukocytes for acute and chronic bacterial subtypes | Identifies causative bacteria (in bacterial subtypes) |
|
✔ | - | - | - | ✔ | ✔ | ✔ | ✔ |
|
||
Epididymitis | Hematuria may be seen | ✔ | Culture | ✔ | ✔ | +/- urethral discharge | ✔ | ✔ | - | ✔ | ✔ | ✔ |
|
*Ultrasound in patients with acute testicular pain to assess for testicular torsion
|
Syphilis (STD) | - | - | Darkfield Microscopy | +/- | - | - | ✔ | - | - | - | - | - |
|
|
BPH | Recommended
Hematuria may be seen |
- | DRE + Serum PSA | - | - | - | ✔ | - | ✔ | ✔ | ✔ |
|
| |
Neoplasms | Recomended
Hematuria may be seen |
- | Imaging and biopsy | +- | - | ✔ | ✔ | - | ✔ | ✔ | - |
|
| |
Pyelonephritis |
|
Identifies causative bacteria | Imaging and culture | ✔ | ✔ + Flank Pain | ✔ | ✔ | ✔ | ✔ | ✔ |
|
|
References
- ↑ Braunwald, Eugene. Heart Disease- Fourth Edition. Harvard Medical School: W. B. SAUNDERS COMPANY. p. 1137. ISBN 0-7216-3097-9.
- ↑ Libre Pathology https://librepathology.org/wiki/File:Cystitis_cystica_et_glandularis_-_alt_--_intermed_mag.jpg Accessed on Jan 13, 2017
- ↑ Radiopaedia.org. Case courtesy of Dr David Little. From the case <a href="https://radiopaedia.org/cases/39307">rID: 39307